Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept. Issue 2 (June 2016)

• Record Type: Journal Article
• Authors: Chowdhry, Sundeep; Shukla, Akhilesh; D'souza, Paschal; Dhali, Tapan; Jaiswal, Prashansa
• Is Part Of: International journal of mycobacteriology. Volume 5:Issue 2(2016:Jun.)
• Page Start: 223
• Page End: 225
• Publication Date: 2016-06
• Subjects: Biologics -- Etanercept -- Erythema nodosum leprosum -- Leprosy -- Treatment; Mycobacteria -- Periodicals; Mycobacterial diseases -- Periodicals; Mycobacteriaceae; Mycobacteria; Electronic journals; Periodicals; 579.374
• DOI: 10.1016/j.ijmyco.2016.02.002
• Languages: English
• ISSNs: 2212-5531

Abstract

Abstract: Erythema nodosum leprosum (ENL) is a common complication of lepromatous leprosy. Some patients unresponsive to conventional, first-line therapeutics develop recurrent, recalcitrant ENL. Here, we report a case of severe refractory ENL that was successfully treated with Etanercept. Biologics may be considered as therapeutic alternatives in management of severe, recalcitrant ENL.